IL104657A - History of benzapine, their preparation and the pharmaceutical preparations containing them - Google Patents
History of benzapine, their preparation and the pharmaceutical preparations containing themInfo
- Publication number
- IL104657A IL104657A IL10465793A IL10465793A IL104657A IL 104657 A IL104657 A IL 104657A IL 10465793 A IL10465793 A IL 10465793A IL 10465793 A IL10465793 A IL 10465793A IL 104657 A IL104657 A IL 104657A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- tetrahydro
- chloro
- benzazepine
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK92233A DK23392D0 (da) | 1992-02-24 | 1992-02-24 | Heterocykliske forbindelser, deres anvendelse og fremstilling |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL104657A0 IL104657A0 (en) | 1993-06-10 |
| IL104657A true IL104657A (en) | 1999-11-30 |
Family
ID=8091236
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL10465793A IL104657A (en) | 1992-02-24 | 1993-02-09 | History of benzapine, their preparation and the pharmaceutical preparations containing them |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP0628039B1 (ru) |
| JP (1) | JPH07504172A (ru) |
| KR (1) | KR100255739B1 (ru) |
| AT (1) | ATE152450T1 (ru) |
| AU (1) | AU667878B2 (ru) |
| BG (1) | BG62208B1 (ru) |
| CA (1) | CA2130678C (ru) |
| CZ (1) | CZ288626B6 (ru) |
| DE (1) | DE69310353T2 (ru) |
| DK (2) | DK23392D0 (ru) |
| ES (1) | ES2102019T3 (ru) |
| FI (1) | FI113770B (ru) |
| GR (1) | GR3023896T3 (ru) |
| HU (1) | HU221314B1 (ru) |
| IL (1) | IL104657A (ru) |
| NO (1) | NO310193B1 (ru) |
| NZ (1) | NZ249465A (ru) |
| RO (1) | RO116088B1 (ru) |
| RU (1) | RU2114839C1 (ru) |
| SK (1) | SK281390B6 (ru) |
| UA (1) | UA34451C2 (ru) |
| WO (1) | WO1993017012A1 (ru) |
| ZA (1) | ZA931099B (ru) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1945495A (en) * | 1994-03-16 | 1995-10-03 | Novo Nordisk A/S | Acid addition salts of 2,3,4,5-tetrahydro-1h-3-benzazepine compounds |
| EP0850237A1 (en) * | 1995-09-15 | 1998-07-01 | Novo Nordisk A/S | Acid addition salts of 2,3,4,5-tetrahydro-1h-3-benzazepine compounds |
| GB0130576D0 (en) * | 2001-12-20 | 2002-02-06 | Cenes Ltd | Dopamine D1 receptor agonist pro-drug compounds & derivatives |
| MX368959B (es) | 2012-10-25 | 2019-10-23 | Tetra Discovery Partners Llc | Inhibidores heteroarilo de pde4. |
| US20150086480A1 (en) * | 2013-09-26 | 2015-03-26 | Tetra Discovery Partners, LLC | Heteroaryl inhibitors of pde4 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK180485D0 (da) * | 1985-04-22 | 1985-04-23 | Novo Industri As | Nitrogenholdige forbindelser |
| DK325188D0 (da) * | 1988-06-15 | 1988-06-15 | Novo Industri As | Hidtil ukendte benzazepinderivater |
| DK67489D0 (da) * | 1989-02-14 | 1989-02-14 | Novo Industri As | Nye benzazepinderivater |
-
1992
- 1992-02-24 DK DK92233A patent/DK23392D0/da not_active Application Discontinuation
-
1993
- 1993-02-05 ES ES93905215T patent/ES2102019T3/es not_active Expired - Lifetime
- 1993-02-05 RO RO94-01400A patent/RO116088B1/ro unknown
- 1993-02-05 UA UA94085741A patent/UA34451C2/ru unknown
- 1993-02-05 RU RU94040719A patent/RU2114839C1/ru not_active IP Right Cessation
- 1993-02-05 CZ CZ19941988A patent/CZ288626B6/cs not_active IP Right Cessation
- 1993-02-05 AT AT93905215T patent/ATE152450T1/de not_active IP Right Cessation
- 1993-02-05 NZ NZ249465A patent/NZ249465A/en unknown
- 1993-02-05 KR KR1019940702944A patent/KR100255739B1/ko not_active IP Right Cessation
- 1993-02-05 SK SK1000-94A patent/SK281390B6/sk unknown
- 1993-02-05 EP EP93905215A patent/EP0628039B1/en not_active Expired - Lifetime
- 1993-02-05 DK DK93905215.5T patent/DK0628039T3/da active
- 1993-02-05 JP JP5514460A patent/JPH07504172A/ja active Pending
- 1993-02-05 WO PCT/DK1993/000041 patent/WO1993017012A1/en active IP Right Grant
- 1993-02-05 DE DE69310353T patent/DE69310353T2/de not_active Expired - Fee Related
- 1993-02-05 HU HU9402434A patent/HU221314B1/hu not_active IP Right Cessation
- 1993-02-05 AU AU36265/93A patent/AU667878B2/en not_active Ceased
- 1993-02-05 CA CA002130678A patent/CA2130678C/en not_active Expired - Fee Related
- 1993-02-09 IL IL10465793A patent/IL104657A/en not_active IP Right Cessation
- 1993-02-17 ZA ZA931099A patent/ZA931099B/xx unknown
-
1994
- 1994-08-22 BG BG98993A patent/BG62208B1/bg unknown
- 1994-08-23 FI FI943875A patent/FI113770B/fi not_active IP Right Cessation
- 1994-08-24 NO NO19943123A patent/NO310193B1/no not_active IP Right Cessation
-
1997
- 1997-06-26 GR GR970401543T patent/GR3023896T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2157668C (en) | Tricyclic 2,3,4,5-tetrahydro-1h-3-benzazepines, their use and preparation | |
| US5010074A (en) | Novel benzazepine derivatives | |
| EP0359790A1 (en) | DERIVATIVES OF 1,4-BENZOXAZINE AND 1,4-BENZOTHIAZINE AND PROCESS FOR THEIR PREPARATION. | |
| EP0628039B1 (en) | 2,3,4,5-tetrahydro-1h-3-benzazepines and pharmaceutically acceptable acid addition salts thereof | |
| US5470850A (en) | 2,3,4,5-tetrahydro-1H-3-benzazepines | |
| US5079243A (en) | Benzazepines | |
| HU193711B (en) | Process for preparing benzazepine derivatives | |
| CA2010059A1 (en) | Benzazepines | |
| DK163993B (da) | 5,7,8-substituerede 2,3,4,5-tetrahydro-1h-3-benzazepiner, fremstilling af disse, samt farmaceutiske praeparater indeholdende disse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| HP | Change in proprietorship | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |